Brief: Anges Inc - Notice Of Marketing Approval Application In Japan For Hgf Gene Therapy Product Collategene
31/05/2023 07:14
May 31 (Reuters) - AnGes Inc 4563.T :
* ANGES INC - NOTICE OF MARKETING APPROVAL APPLICATION IN
JAPAN
FOR HGF GENE THERAPY PRODUCT COLLATEGENE
Source text for Eikon: ID:nTSqe8fe7e
Further company coverage: 4563.T
(Reporting by Rocky Swift)
((rocky.swift@thomsonreuters.com;))
Recent news on AnGes
See all newsTable: Anges -Q1 group results
Brief: Vasomune Therapeutics, Inc., And Anges, Inc., Announce Us FDA Clearance Of Investigational New Drug (Ind) Application For Pegevongitide (Av-001) Treatment In Resuscitation Of Severely Burned Patients
Table: Anges -2025 parent results
Table: Anges -2025 group results
Brief: Anges & Vasomune Therapeutics Enter Agreement For AV-001